Add to Favourites
To login click here
LabGenius, a London-based drug discovery company, has raised £35M in a Series B funding round led by M Ventures. The company uses machine learning and a smart robotic platform to discover new therapeutic antibodies. LabGenius operates under a hybrid business model and is also developing its own therapeutic pipeline.
